Canada markets closed

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
16.14+0.12 (+0.75%)
At close: 04:00PM EDT
15.84 -0.30 (-1.86%)
After hours: 06:43PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 384.66M
Enterprise Value 134.19M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)24.79
Price/Book (mrq)2.08
Enterprise Value/Revenue 8.67
Enterprise Value/EBITDA -0.69

Trading Information

Stock Price History

Beta (5Y Monthly) 2.80
52-Week Change 3-54.32%
S&P500 52-Week Change 3-8.83%
52 Week High 365.00
52 Week Low 311.70
50-Day Moving Average 318.56
200-Day Moving Average 330.87

Share Statistics

Avg Vol (3 month) 3755.22k
Avg Vol (10 day) 31.19M
Shares Outstanding 526.42M
Implied Shares Outstanding 6N/A
Float 822.75M
% Held by Insiders 113.90%
% Held by Institutions 178.07%
Shares Short (May 30, 2022) 43.34M
Short Ratio (May 30, 2022) 44.99
Short % of Float (May 30, 2022) 419.59%
Short % of Shares Outstanding (May 30, 2022) 412.63%
Shares Short (prior month Apr 28, 2022) 43.05M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 15, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Nov 15, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-1,263.67%

Management Effectiveness

Return on Assets (ttm)-29.69%
Return on Equity (ttm)-73.88%

Income Statement

Revenue (ttm)15.48M
Revenue Per Share (ttm)0.59
Quarterly Revenue Growth (yoy)146.50%
Gross Profit (ttm)12.36M
EBITDA -194.46M
Net Income Avi to Common (ttm)-198.5M
Diluted EPS (ttm)-7.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)319.68M
Total Cash Per Share (mrq)12.1
Total Debt (mrq)69.2M
Total Debt/Equity (mrq)37.46
Current Ratio (mrq)3.05
Book Value Per Share (mrq)7.00

Cash Flow Statement

Operating Cash Flow (ttm)-141.13M
Levered Free Cash Flow (ttm)-70.54M